# Alkem Medtech to acquire 55% stake in Occlutech for EUR 99.4 million

Alkem Medtech, a subsidiary of Alkem Laboratories, has executed a binding offer to acquire up to a 55% stake in Swiss medical devices company Occlutech Holding AG for EUR 99.4 million (about ₹1,074 crore). The acquisition marks Alkem's entry into advanced cardiovascular devices.

- Type: Acquisition
- Announced: 2026-02-13
- Where: Switzerland
- Value: $107.0M (99.4M EUR)
- Status: announced
- Products: minimally invasive cardiac implants, cardiovascular devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alkem Laboratories](https://endata.com/companies/74928.md) (partner)
- [Alkem MedTech Pvt Ltd](https://endata.com/companies/79365.md) (acquirer)
- [Occlutech Holding AG](https://endata.com/companies/90359.md) (target)

## Sources

- [thehindubusinessline.com](https://www.thehindubusinessline.com/companies/alkem-medtech-to-pick-up-majority-stake-in-swiss-medical-devices-co-for-1074-crore/article70628973.ece), 2026-02-13: "The acquisition of Occlutech opens up significant opportunities for Alkem MedTech, and reinforces Alkem’s long-term vision of becoming a global player in the medical devices industry."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.